Cambridge Healthtech Institute’s Inaugural
Emerging Peptide Therapeutics
Discovery, Engineering, and Design
May 14-15, 2026
Peptide drug discovery has experienced a revival of interest and scientific momentum. This class of compounds is making headlines daily, and the industry has come to appreciate the role that peptide therapeutics can play in addressing unmet medical needs. The Emerging Peptide Therapeutics conference at PEGS Boston on May 14-15 covers discovery, engineering, and design in this exciting area and will feature half-life extended peptides, GLP-1 agonists, and applications beyond obesity and diabetes. Come learn how engineering strides are being made to allow peptides to compete and combine with established modalities.
Coverage will include, but is not limited to:
- Designing novel peptides with extended half-life and more drug-like properties
- Targeting indications beyond diabetes, obesity, and metabolic diseases to include cardiovascular and Alzheimer’s diseases
- Addressing cell-surface targets
- Generating novel cyclic and macrocyclic peptides
- Computationally guided design of peptides
- Exploring peptide structure prediction using AI/ML technologies
The deadline for priority consideration is October 17, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: